117 related articles for article (PubMed ID: 8551064)
1. TPS cytosolic levels in non-malignant breast diseases.
Alvarez A; Martinez Rodriguez PI; Nuñez MI; Alba A; Allende MT; Ruibal Morell A
Int J Biol Markers; 1995; 10(3):183-5. PubMed ID: 8551064
[No Abstract] [Full Text] [Related]
2. Expression of c-kit in common benign and malignant breast lesions.
Kondi-Pafiti A; Arkadopoulos N; Gennatas C; Michalaki V; Frangou-Plegmenou M; Chatzipantelis P
Tumori; 2010; 96(6):978-84. PubMed ID: 21388062
[TBL] [Abstract][Full Text] [Related]
3. Different patterns of HLA-DR antigen expression in normal epithelium, hyperplastic and neoplastic malignant lesions of the breast.
Concha A; Ruiz-Cabello F; Cabrera T; Nogales F; Collado A; Garrido F
Eur J Immunogenet; 1995 Aug; 22(4):299-310. PubMed ID: 7495782
[TBL] [Abstract][Full Text] [Related]
4. Patients With Invasive Ductal Carcinoma Have Reduced Levels of Decorin Expression in Their Breast Tissue Compared to Patients With Fibroadenoma While Plasma Decorin Remains Unchanged.
Falakian Z; Shahani T; Rezaie R; Mazloomzadeh S; Sirati F; Jalilvand A; Jahangiri F; Bahmani P; Jadali F; Atarian S; Eghdam-Zamir R; Biglari A
Arch Iran Med; 2018 Nov; 21(11):509-517. PubMed ID: 30551691
[TBL] [Abstract][Full Text] [Related]
5. A comparison of the patterns of laminin expression in fibroadenoma, fibrocystic diseases, pre-invasive and invasive ductal breast carcinoma.
Zheng WQ; Looi LM; Cheah PL
Pathology; 2001 Aug; 33(3):303-6. PubMed ID: 11523929
[TBL] [Abstract][Full Text] [Related]
6. Proliferating cell nuclear antigen (PCNA) expression in patients with breast carcinoma in comparison to patients with benign breast diseases.
Kalogeraki A; Tzardi M; Datseris G; Kanavaros P; Karvelas C; Chalkiadakis G; Tsiftsis D; Delides G
In Vivo; 1994; 8(6):1053-6. PubMed ID: 7772736
[TBL] [Abstract][Full Text] [Related]
7. P53 expression in patients with malignant and benign breast diseases.
Kalogeraki A; Panayiotides J; Tamiolakis D; Tzardi M; Chaniotis V; Chalkiadakis G; Melissas J; Stiftsis D; Kanavaros P; Delides GS
Anticancer Res; 2000; 20(3A):1801-5. PubMed ID: 10928110
[TBL] [Abstract][Full Text] [Related]
8. [P21 expression of ras oncogene product in benign and malignant female mammary lesions].
Zhang JZ; Fan SC; Liu HF
Zhonghua Bing Li Xue Za Zhi; 1994 Oct; 23(5):302-3. PubMed ID: 7874767
[TBL] [Abstract][Full Text] [Related]
9. p53 protein expression in benign and malignant breast lesions.
Ioakim-Liossi A; Markopoulos C; Karakitsos P; Safioleas M; Gogas J; Vaiopoulos G
Acta Cytol; 1998; 42(4):918-22. PubMed ID: 9684577
[TBL] [Abstract][Full Text] [Related]
10. Immunocytochemical detection of carcinoembryonic antigen in fine-needle aspirates from patients with diverse breast diseases.
Alexiev BA; Valkov IN; Popov AA; Marinov VS
Diagn Cytopathol; 1993 Aug; 9(4):377-82. PubMed ID: 8261842
[TBL] [Abstract][Full Text] [Related]
11. The phosphorylated form of connexin43 is up-regulated in breast hyperplasias and carcinomas and in their neoformed capillaries.
Gould VE; Mosquera JM; Leykauf K; Gattuso P; Dürst M; Alonso A
Hum Pathol; 2005 May; 36(5):536-45. PubMed ID: 15948121
[TBL] [Abstract][Full Text] [Related]
12. Lectin binding patterns in benign and malignant lesions of the breast.
Karuna V; Shanthi P; Madhavan M
Indian J Pathol Microbiol; 1992 Oct; 35(4):289-97. PubMed ID: 1344218
[TBL] [Abstract][Full Text] [Related]
13. Consistent lack of CD34-positive stromal cells in the stroma of malignant breast lesions.
Kuroda N; Jin YL; Hamauzu T; Toi M; Miyazaki E; Hiroi M; Moriki T; Enzan H
Histol Histopathol; 2005 Jul; 20(3):707-12. PubMed ID: 15944918
[TBL] [Abstract][Full Text] [Related]
14. Occurrence and de novo biosynthesis of follicle stimulating hormone (FSH) in benign and malignant conditions of human breast.
Garde SV; Sheth AR; Joseph R; Panchal CJ; Chinoy RF; Sheth NA
Cancer Lett; 1993 Nov; 75(1):1-9. PubMed ID: 8287377
[TBL] [Abstract][Full Text] [Related]
15. Sera from breast cancer patients contain an IgA antibody to a breast cyst fluid component.
Witkin SS; Richards JM; Bongiovanni AM; Breed CN; Day NK
Clin Immunol Immunopathol; 1982 May; 23(2):358-65. PubMed ID: 6286196
[No Abstract] [Full Text] [Related]
16. Elevated levels of prostate-specific antigen in serum of women with fibroadenomas and breast cysts.
Borchert GH; Giai M; Diamandis EP
J Natl Cancer Inst; 1997 Apr; 89(8):587-8. PubMed ID: 9106652
[No Abstract] [Full Text] [Related]
17. CD44 isoforms with exon v6 and metastasis of primary N0M0 breast carcinomas.
Guriec N; Gairard B; Marcellin L; Wilk A; Caldéroli H; Renaud R; Bergerat JP; Oberling F
Breast Cancer Res Treat; 1997 Jul; 44(3):261-8. PubMed ID: 9266106
[TBL] [Abstract][Full Text] [Related]
18. [Expression of the adhesion molecule CD44v6 in infiltrating ductal carcinomas of the breast is associated with hormone dependence. Our experience with 168 cases].
Ruibal A; Schneider J; del Río MC; Arias J; Núñez MI; Tejerina A
Rev Esp Med Nucl; 2000 Sep; 19(5):350-5. PubMed ID: 11062111
[TBL] [Abstract][Full Text] [Related]
19. High expression of the antigen recognized by the monoclonal antibody GB24 on human breast carcinomas: a preventive mechanism of malignant tumor cells against complement attack?
Hofman P; Hsi BL; Manie S; Fenichel P; Thyss A; Rossi B
Breast Cancer Res Treat; 1994; 32(2):213-9. PubMed ID: 7532466
[TBL] [Abstract][Full Text] [Related]
20. Expression of hyaluronan in benign and malignant breast lesions.
Auvinen PK; Parkkinen JJ; Johansson RT; Agren UM; Tammi RH; Eskelinen MJ; Kosma VM
Int J Cancer; 1997 Oct; 74(5):477-81. PubMed ID: 9355968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
